PulseAugur
EN
LIVE 00:04:04
中文(ZH) 上海出台若干措施,支持生物医药外资企业高能级项目落地

Shanghai supports foreign biopharma; SoftBank eyes Japan AI data centers

Shanghai has introduced new measures to support high-level projects from foreign-funded biopharmaceutical companies. These initiatives aim to expedite the approval and distribution of imported drugs, including streamlining customs clearance and reducing inspection requirements for biological products. Concurrently, SoftBank Group's chairman indicated plans to invest in Tokyo Electric Power Company, with the goal of establishing AI data centers in Japan. AI

IMPACT These developments signal increased global investment in AI infrastructure and supportive regulatory environments for related industries.

RANK_REASON The cluster contains policy changes impacting foreign investment in biopharmaceuticals and a significant investment plan for AI data centers. [lever_c_demoted from significant: ic=1 ai=0.7]

Read on 36氪 (36Kr) →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

Shanghai supports foreign biopharma; SoftBank eyes Japan AI data centers

COVERAGE [1]

  1. 36氪 (36Kr) TIER_1 中文(ZH) ·

    Shanghai Introduces Several Measures to Support High-Level Projects of Foreign-Funded Biomedical Enterprises

    36氪获悉,上海市科委、市发展改革委等部门联合发布《关于支持生物医药外资企业高能级项目落地的若干措施》。其中提出,加快进口药品销售流通。境外已上市药品在取得我国药品批准证明文件后,对符合药品上市放行要求的获批前生产的药品,可以上市销售,加强对其业务指导与服务。深化药品进口通关抽样一体化、24小时通关便利化,加速临床急需进口药品流通应用。加快生物制品批签发检验和进口药品通关检验速度,确保进口药品到港后3个工作日内实施抽样,并将每批次用量从全项检验用量的3倍减为2倍。